Abiopharma

DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference

New Form 8-K - Gryphon Digital Mining, Inc. Filed: 2025-09-02 AccNo: 0001213900-25-082930 Size: 960 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 3 - Mural Oncology plc Filed: 2025-09-02 AccNo: 0001963860-25-000040 Size: 3 KB

Hoth Therapeutics Notification (HOTH)

New Form 424B5 - Merck & Co., Inc. Filed: 2025-09-02 AccNo: 0000310158-25-000027 Size: 668 KB

New Form SCHEDULE 13D/A - Senti Biosciences, Inc. Filed: 2025-09-02 AccNo: 0000902664-25-003924 Size: 12 KB

Hoth Therapeutics Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards

New Form 6-K - ALTERITY THERAPEUTICS LTD Filed: 2025-09-02 AccNo: 0001213900-25-082928 Size: 46 KB

Hyperfine Receives CE Mark and UKCA Approval for OptiveAI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

Thermo Fisher Scientific - Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site

New Form S-3MEF - Sharps Technology Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026141 Size: 228 KB

New Form 6-K - SMITH & NEPHEW PLC Filed: 2025-09-02 AccNo: 0001654954-25-010259 Size: 16 KB

New Form 8-K - KALA BIO, Inc. Filed: 2025-09-02 AccNo: 0001104659-25-086011 Size: 220 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter